Back
Lucid Group Vs. Viking Therapeutics Industry Stock Comparison
Sell
46
LCID
Lucid Group
Last Price:
3.98
Seasonality Move:
9.17%
Buy
77
VKTX
Viking Therapeutics
Last Price:
60.81
Seasonality Move:
18.67%
Sell
46
Lucid Group (LCID)
is a Sell
Is Lucid Group a Buy, Sell or Hold?
- The current Lucid Group [LCID] share price is $3.98. The Score for LCID is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- LCID is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $60.83. The Score for VKTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LCID Stock Price Chart
What is Lucid Group's stock price today?
-
The Lucid Group share price today is $3.98
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LCID is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $60.83
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LCID Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 59.58 | Buy |
| Chaikin Money Flow: | 42424100 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.15 - 3.97) | Buy |
| Bollinger Bands (100): | (2.59 - 3.57) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 53.83 | Buy |
| Chaikin Money Flow: | 4941502 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.23 - 63.83) | Buy |
| Bollinger Bands (100): | (51.87 - 68.79) | Buy |
LCID Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.73 | Buy |
| 20-day SMA: | 3.68 | Buy |
| 50-day SMA: | 3.46 | Buy |
| 200-day SMA: | 3.25 | Buy |
| 8-day EMA: | 3.73 | Buy |
| 20-day EMA: | 3.66 | Buy |
| 50-day EMA: | 3.44 | Buy |
| 200-day EMA: | 3.73 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.57 | Buy |
| 20-day SMA: | 60.48 | Buy |
| 50-day SMA: | 57.19 | Buy |
| 200-day SMA: | 50.9 | Buy |
| 8-day EMA: | 57.88 | Buy |
| 20-day EMA: | 58.77 | Buy |
| 50-day EMA: | 58.42 | Buy |
| 200-day EMA: | 50.41 | Buy |
Lucid Group Earnings Growth & LCID Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.03 per share, an increase this year of $0.23 per share, and an increase next year of $0.25 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.55 per share.
Lucid Group Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||